---

Q8. Hypertension - Risk Factors & Plan to Estimate Burden (3+7=10) [JMNMCH]

a) Risk Factors of Hypertension (3 marks)

1. Age - BP rises progressively with age in both sexes; greater rise in those with higher initial BP
2. Sex - Males show higher average levels post-adolescence; post-menopausal women show a relative rise
3. Genetic factors - Polygenic inheritance; children of two hypertensive parents have 45% risk vs. 3% in normotensive parents; monozygotic twins show stronger BP correlation
4. Ethnicity - Black communities have consistently higher BP than other groups

1. Obesity - Central obesity (increased waist:hip ratio) positively correlated with high BP; weight loss generally decreases BP
2. Salt intake - High salt intake (>7-8 g/day) increases BP proportionately; Japan (>400 mmol/day) has high HTN prevalence; primitive societies (<60 mmol/day) have virtually no hypertension
3. Alcohol - Excess alcohol intake raises BP
4. Physical inactivity - Sedentary lifestyle increases risk
5. Psychosocial stress - Type A personality, occupational stress
6. Smoking - Raises BP acutely; associated with atherosclerosis
7. Oral contraceptives - Estrogen-containing pills can raise BP
8. Dyslipidaemia - Associated with cardiovascular risk

---

b) Plan to Estimate Burden of Hypertension in a Community (7 marks)

Step 1: Define the Study Area and Population

• Define the catchment area of the Community Health Centre
• Enumerate the adult population (aged 18+) using household listing
• Define hypertension as BP ≥140/90 mmHg (on two separate occasions) or on antihypertensive medication

Step 2: Sampling

• Use stratified multistage random sampling to ensure representation across urban/rural, age, and sex groups
• Calculate adequate sample size (using estimated prevalence ~30%, 95% CI, 5-10% allowable error)

Step 3: Data Collection Tool

• Standardized questionnaire covering:
  • Sociodemographic data (age, sex, education, occupation, SES)
  • Known history of hypertension and duration
  • Current medications
  • Dietary habits, salt intake, alcohol, smoking
  • Physical activity
  • Family history
• Anthropometry: height, weight, waist and hip circumference, BMI
• Blood pressure measurement: using calibrated mercury/aneroid sphygmomanometer or validated digital device; at least 2 readings 5 minutes apart in seated position; both arms; average taken

Step 4: Case Definition

• Hypertension: SBP ≥140 mmHg and/or DBP ≥90 mmHg on ≥2 separate visits, OR currently on antihypertensive medication
• Pre-hypertension: SBP 130-139/DBP 80-89
• Record Stage 1 (140-159/90-99) and Stage 2 (≥160/≥100) separately

Step 5: Measures of Burden to be Estimated

• Prevalence (detected + undetected cases)
• Awareness rate - proportion of hypertensives who knew their diagnosis
• Treatment rate - proportion of known hypertensives on treatment
• Control rate - proportion of treated on adequate control (Rule of Halves concept)
• Iceberg magnitude - proportion of undetected cases

Step 6: Identify Risk Factors

• Logistic regression analysis to identify significant risk factors in the community

Step 7: Analysis and Report

• Calculate age- and sex-adjusted prevalence rates
• Compare with state/national estimates
• Identify high-risk subgroups
• Report findings to local health authorities for planning

Step 8: Ethical Considerations

• Institutional Ethics Committee approval
• Informed written consent from all participants
• Referral of detected cases to the Health Centre for management

---

---

Q9. Modifiable Risk Factors of Hypertension + Levels of Prevention & Modes of Intervention for RTA (3+7) [JHARGRAM]

Modifiable Risk Factors of Hypertension (3 marks)

1. Obesity/overweight - BMI >25, central obesity (increased waist:hip ratio)
2. High salt intake - >5 g/day of dietary sodium
3. Alcohol consumption - Excess alcohol raises BP
4. Physical inactivity - Sedentary lifestyle
5. Stress - Psychosocial stress, Type A behaviour pattern
6. Smoking - Nicotine raises BP acutely; atherosclerosis long-term
7. Oral contraceptive pills - Estrogen raises BP, particularly in older women
8. Dyslipidaemia - Contributes to cardiovascular risk
9. Dietary deficiency of potassium and calcium - Low K+ diet associated with higher BP

---

Levels of Prevention and Modes of Intervention for Road Traffic Accidents (7 marks)

Levels of Prevention

• Prevention of risk factors before they emerge in the community
• Town planning: separate pedestrian paths, cycling tracks, flyovers
• Road design standards incorporating safety features from inception
• National road safety policy and traffic laws

• Prompt emergency care at accident site (Golden Hour)
• Trained first-aid personnel at accident scenes
• Emergency Ambulance services (108 service in India)
• Organized Accident Services and Trauma Care Hospitals in major cities
• Helmet use reduces risk of death by ~40% and severe injury by >70%
• Seat belts reduce fatality among front-seat passengers by 40-50%

• Medical rehabilitation: treatment of injuries, fractures, TBI
• Social rehabilitation: reintegration
• Occupational rehabilitation: return to work
• Disability compensation

Haddon Matrix Framework (3-phase approach)

---

---

Q10. Classification of DM + Modifiable Risk Factors of T2DM + Role of PHC (3+2+5) [DMGMCH]

Classification of Diabetes Mellitus (3 marks)

---

Modifiable Risk Factors of Type 2 DM (2 marks)

1. Overweight/obesity (BMI >25) and abdominal obesity - Convincing evidence
2. Physical inactivity/sedentary lifestyle - Alters insulin-receptor interaction
3. Unhealthy diet - High saturated fat intake, low dietary fibre, high glycaemic index foods
4. Alcohol excess - Damages pancreas, promotes obesity
5. Tobacco smoking - Associated with insulin resistance
6. Stress - Promotes cortisol-driven glucose elevation
7. Diabetogenic drugs - Corticosteroids, thiazide diuretics, oral contraceptives

---

Role of Primary Health Care in Prevention and Control of Type 2 DM (5 marks)

• Health education: Awareness about risk factors, symptoms, complications, healthy diet, regular exercise
• Behavioural counselling: Promotion of weight reduction, physical activity (minimum 30 min moderate exercise/day), dietary fibre intake (≥20 g/day), reduction of saturated fat
• Primordial prevention: Integrate prevention into community NCD programs
• Screening of high-risk groups: Age ≥40 years, family history, obese, women with GDM history, babies >4.5 kg, premature atherosclerosis patients

• Detection under NP-NCD screening: Fasting blood glucose ≥7.0 mmol/L (126 mg/dL) or 2-h post-load ≥11.1 mmol/L (200 mg/dL) or HbA1c ≥6.5%, or random glucose ≥11.1 mmol/L
• Regular opportunistic screening at OPD level

• Diet therapy: small balanced frequent meals; low glycaemic index; high fibre
• Oral antidiabetic drugs (OHA) - metformin, SUs, etc.
• Insulin where indicated
• Monitoring: regular blood glucose, urine protein, BP, visual acuity, weight, foot examination

• Regular HbA1c (target <7%) at 6-monthly intervals
• Screening for retinopathy, nephropathy, neuropathy
• Foot care education; Doppler ultrasound for peripheral vascular disease
• BP and lipid control

• Teach patient blood glucose self-monitoring, urine testing, insulin self-administration, recognition of hypoglycaemia symptoms, dietary adherence

• Timely referral to secondary/tertiary centre for complications
• Maintain diabetes register; track defaulters

---

---

Q11. Clinical Case - DM (BMI 31, Glucose 432) [DHGMCH]

a) Four Modifiable Risk Factors of DM (2 marks)

1. Obesity/overweight - This patient has BMI 31 kg/m² (Class I Obesity), the strongest modifiable risk factor for T2DM
2. Physical inactivity - Sedentary lifestyle increases insulin resistance
3. Unhealthy diet - High saturated fat, low fibre, high glycaemic index foods
4. Tobacco and alcohol use - Both worsen glycaemic control and insulin resistance

b) Target Age Group for Population-Based Screening Under NP-NCD (1 mark)

• Under the National Programme for Prevention and Control of NCDs (NP-NCD), population-based screening targets individuals aged 30 years and above for diabetes, hypertension, and common cancers (oral, breast, cervical) - conducted at Ayushman Arogya Mandirs (formerly Health and Wellness Centres)

c) One Objective of NP-NCD (1 mark)

• "To prevent and control common NCDs (cardiovascular diseases, diabetes, cancers and stroke) through behaviour and lifestyle changes"
• Alternatively: To provide early diagnosis, treatment, and follow-up for NCDs at the primary care level through universal health coverage

---

---

Q12. Diagnosis of Hypertension at H&WC + Modifiable Risk Factors + National Programme Strategies (3+3+4) [CMSDH]

A. Process to Diagnose Hypertension at Health & Wellness Centre (3 marks)

1. Measurement technique:
   • Patient seated quietly for 5 minutes before measurement
   • Use calibrated sphygmomanometer (mercury/aneroid/validated digital)
   • Proper cuff size (cuff bladder encircles ≥80% of arm circumference)
   • Arm at heart level, two readings taken 5 minutes apart, average recorded
   • Measure both arms on first visit; use arm with higher reading
2. Classification (JNC/WHO):
   • Normal: <120/80 mmHg
   • Elevated/Pre-hypertension: SBP 120-139 / DBP 80-89
   • Stage 1 HTN: SBP 140-159 / DBP 90-99
   • Stage 2 HTN: SBP ≥160 / DBP ≥100
3. Confirmation: BP must be elevated on two separate occasions (at least 2 visits, 1-4 weeks apart) before diagnosis is confirmed (unless severely elevated with end-organ damage)
4. Secondary HTN evaluation: Rule out renal, endocrine, or drug-induced causes; urine examination, blood glucose, creatinine, ECG, fundoscopy

---

B. Modifiable Risk Factors of Hypertension (3 marks)

1. Obesity/overweight
2. High dietary salt intake (>5 g/day)
3. Alcohol excess
4. Physical inactivity
5. Psychosocial stress
6. Smoking
7. Oral contraceptive pills
8. Dyslipidaemia
9. Low potassium/calcium diet

---

C. Strategies Under National Programme to Prevent and Control Hypertension (4 marks)

• Universal screening of all individuals ≥30 years at Ayushman Arogya Mandirs (AAM/H&WC)
• CBAC (Community Based Assessment Checklist) used by ASHAs for risk stratification at doorstep

• Promotive messaging on diet (DASH diet, reduced salt), physical activity, tobacco cessation, alcohol reduction
• National SALT reduction policy (WHO target: reduce salt intake to <5 g/day)
• Tobacco Control under NTCP

• Standardized treatment protocols at sub-centre/PHC level
• Essential medicines for HTN listed under National Essential Medicines List (amlodipine, atenolol, enalapril, hydrochlorothiazide)
• Free medicines supplied through Jan Aushadhi scheme

• NCD Registry for tracking hypertensives
• Nikshay-like NPCDCS portal for follow-up
• Digital CBAC linked to health ID

• Ministry of Food for salt regulation
• Ministry of Education for lifestyle education in schools
• Ministry of Urban Development for walkable infrastructure

• AAM (screening) → PHC (diagnosis and basic treatment) → CHC/District Hospital (complicated cases) → Tertiary for resistant hypertension

---

---

Q13. Iceberg Phenomenon in Hypertension + Primordial/Primary/Secondary Prevention [BGMCH]

Concept of Iceberg Phenomenon in Hypertension

• Above the waterline (visible tip): These are the clinically detected cases of hypertension - patients who have been diagnosed, are symptomatic, or have presented to a physician
• Waterline: Represents the threshold between apparent and inapparent disease
• Below the waterline (submerged mass): The vast, hidden portion comprising:
  • Undiagnosed hypertensives (not yet screened)
  • Presymptomatic cases (BP elevated but no symptoms - the "silent killer" stage)
  • Borderline/pre-hypertensive cases
  • White-coat hypertensives and masked hypertensives

• Hypertension is largely asymptomatic - hence called the "silent killer"
• Studies show that only about 50% of hypertensives are aware of their diagnosis
• Of those aware, only ~50% are on treatment
• Of those on treatment, only ~50% are adequately controlled
• This is the Rule of Halves - a direct manifestation of the iceberg
• The undetected submerged portion is therefore much larger than the detected tip

• The hidden reservoir poses risk of sudden strokes, MI, renal failure without warning
• Detection of the submerged portion through screening is the key challenge
• Community-based screening programs aim to raise the "waterline" - i.e., detect cases earlier

---

Prevention Strategies

• Creating healthy environments: low-sodium food policy, trans-fat bans, building walkable cities
• National nutrition programs discouraging excess salt consumption
• School curriculum integrating healthy lifestyle education from childhood
• Urban planning ensuring parks, cycling tracks, pedestrian-friendly roads
• Tobacco and alcohol control policies (COTPA, GST on tobacco/alcohol)

• Reducing the average BP of the whole population - even a small downward shift produces large reductions in cardiovascular events
• DASH diet promotion (Dietary Approaches to Stop Hypertension)
• Reduction of dietary salt to <5 g/day
• Mass media health education campaigns
• Promotion of physical activity (30 min/day moderate exercise)
• Weight reduction programs in obese individuals
• Stress reduction: yoga, meditation, counselling

• Identify individuals at high risk (family history, obese, diabetic, dyslipidaemic) through CBAC screening
• Target intensive lifestyle intervention at this group
• Monitor pre-hypertensives (120-139/80-89 mmHg) regularly

• Early detection: Opportunistic and organized BP screening at H&WCs (Ayushman Arogya Mandirs) for all adults ≥30 years
• Prompt treatment: Lifestyle modification + pharmacotherapy as per JNC/WHO guidelines
• Adherence support: Drug supply under NP-NCD; patient education
• Monitoring: Regular BP follow-up, HbA1c, lipids, renal function, ECG, fundoscopy
• Complication prevention: Tight BP control (<130/80 mmHg) reduces stroke, MI, and renal failure risk
• Self-BP monitoring with log-book maintenance (home BP monitoring)

---

---

Q14. Epidemiological Determinants of Diabetes + Primary Prevention (5+5=10) [SMCH]

A. Epidemiological Determinants of Diabetes (5 marks)

1. Agent Factors

• The underlying cause is insulin deficiency - absolute in Type 1, partial in Type 2
• Mechanisms include:
  • Pancreatic disorders: inflammatory, neoplastic, cystic fibrosis
  • Defects in insulin synthesis (abnormal insulin molecule)
  • Beta-cell destruction by viral infections (rubella, mumps, Coxsackie B4) and chemical agents
  • Decreased insulin sensitivity due to reduced receptor numbers on adipocytes and monocytes (Type 2)
  • Autoimmune destruction (Type 1) - anti-islet cell antibodies

2. Host Factors

• Age: Type 2 DM prevalence rises sharply after age 40; peak in 50s-60s; Type 1 peaks in childhood/adolescence
• Sex: No significant sex difference in Type 2 DM in India (12% males vs 11.7% females, Govt of India survey 2019)
• Genetic susceptibility:
  • Type 1: HLA-DR3, HLA-DR4 associations; concordance in identical twins 30-50%
  • Type 2: Concordance in identical twins >90%; polygenic
  • Family history: First-degree relative with DM = 2-3x increased risk
• Ethnicity: South Asians (including Indians) have higher susceptibility - demonstrated in migrant Indian populations (Fiji, Singapore, South Africa, UK, USA) who consistently exceed local population diabetes rates
• Obesity: BMI >25 (overweight), especially abdominal/central obesity - strongest modifiable host factor
• Previous gestational diabetes
• Parity: Women who delivered babies >4.5 kg

3. Environmental Factors

• Sedentary lifestyle: Physical inactivity alters insulin-receptor interaction; risk factor with convincing evidence
• Dietary factors:
  • High saturated fat intake: associated with impaired glucose tolerance
  • Low dietary fibre: high NSP/fibre intake is protective (reduces blood glucose and insulin levels)
  • High glycaemic index foods: promote postprandial hyperglycaemia
  • Malnutrition (PEM) in infancy: may cause partial beta-cell dysfunction
• Alcohol: Damages pancreas, promotes obesity, increases risk
• Stress: Cortisol and catecholamines antagonize insulin action
• Urbanization: Urban India prevalence 10.9-14.2% vs rural 3.0-7.8% (adults ≥20 yrs)
• Socioeconomic factors: High-income countries historically higher, but now rising rapidly in LMICs

4. Time, Place, Person

• India has 77 million diabetics (2nd in world after China)
• Prevalence: 11.8% overall (Govt survey 2019)
• Type 2 DM rising trend: urbanization, lifestyle change, aging population
• Global rise: 108 million in 1980 → 422 million in 2014 (WHO)

---

B. Primary Prevention of Diabetes (5 marks)

a. Population Strategy

• Primordial prevention - prevent emergence of risk factors in the community
• Goal: Maintain normal body weight through healthy nutrition and regular physical exercise
• Key interventions:
  1. Dietary modification: adequate protein, high dietary fibre (≥20 g/day), avoidance of sweet/high GI foods, reduction in saturated fat, increased polyunsaturated/monounsaturated fat
  2. Physical activity promotion: minimum 150 min/week moderate-intensity aerobic activity; reduces insulin resistance and promotes weight loss
  3. Weight management: Voluntary weight loss in overweight/obese individuals - "convincing" evidence of reduced DM risk (WHO classification)
  4. Tobacco cessation: Smoking increases insulin resistance
  5. Reduction of alcohol intake
  6. Community-wide programs: Integrate DM prevention into broader NCD prevention programs (CVD, HTN) - shared risk factors allow combined approach
  7. Health education: Public awareness about risk factors, benefits of lifestyle change
  8. Policy measures: Food labelling, taxation of sugar-sweetened beverages, school nutrition programs

b. High-Risk Strategy (Selective Primary Prevention)

• Target individuals at high risk for T2DM:
  • Age ≥40 years
  • Obese (BMI >25)
  • Family history of DM
  • Previous gestational diabetes
  • Premature atherosclerosis
  • Impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) - prediabetes
• Interventions for high-risk groups:
  • Structured lifestyle modification programs (Finnish DPS, DPP trials show 58% risk reduction with lifestyle changes vs 31% with metformin)
  • Correction of overweight/obesity
  • Avoid diabetogenic drugs (thiazides, corticosteroids, OCPs where possible)
  • Regular fasting glucose monitoring every 6-12 months
  • Metformin for those with IGT + other risk factors (high-risk subset)
  • Avoidance of excess alcohol
  • Treatment of dyslipidaemia, hypertension (reduce overall metabolic risk)

Under NP-NCD:

• Opportunistic screening at Ayushman Arogya Mandirs for all adults ≥30 years
• ASHA-administered CBAC (Community Based Assessment Checklist) for household-level risk identification
• Lifestyle counselling at H&WC level by health and wellness promoters (HWPs/MPHWs)
• Integration with POSHAN Abhiyaan for early nutrition interventions
• Free medicines and follow-up under NP-NCD framework

---